Protagonist Therapeutics Inc buy Citigroup Inc.
Start price
17.07.26
/
50%
€124.00
Target price
17.07.27
-
Performance (%)
-4.03%
Price
31.07.26
€119.00
Summary
This prediction is currently active. With a performance of -4.03%, the BUY prediction for Protagonist Therapeutics Inc by Citigroup_Inc_ is down slightly. This prediction currently runs until 17.07.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Protagonist Therapeutics Inc | -0.833% |
| iShares Core DAX® | 2.591% |
| iShares Nasdaq 100 | -0.915% |
| iShares Nikkei 225® | 0.145% |
| iShares S&P 500 | -0.367% |
Comments by Citigroup_Inc_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its "outperform" rating reaffirmed by Citigroup Inc..
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€88.00
19.03.26
19.03.26
€108.80
19.03.27
19.03.27
35.23%
31.07.26
31.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€74.00
10.11.25
10.11.25
€84.79
10.11.26
10.11.26
60.81%
31.07.26
31.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
07.08.25
07.08.25
-
07.08.26
07.08.26
172.94%
31.07.26
31.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€46.40
17.06.25
17.06.25
€62.32
17.06.26
17.06.26
112.28%
18.06.26
18.06.26